ACOG
ACOG
NASDAQ · Biotechnology

Alpha Cognition Inc

$7.22
+0.41 (+6.02%)
As of Jun 30, 10:32 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.56M
Net Income
-25,397,269
Gross Margin
81.3%
Profit Margin
-202.2%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.3% 41.1% 41.1% 41.1%
Operating Margin -221.7% -6.9% -7.2% -7.2%
Profit Margin -202.2% -5.6% -6.7% -6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.56M 16.36M 16.49M 13.84M
Gross Profit 10.21M 6.72M 6.78M 5.68M
Operating Income -27,844,741 -1,134,163 -1,187,945 -993,114
Net Income -25,397,269 -919,800 -1,097,385 -862,011
Gross Margin 81.3% 41.1% 41.1% 41.1%
Operating Margin -221.7% -6.9% -7.2% -7.2%
Profit Margin -202.2% -5.6% -6.7% -6.2%
Rev Growth +3.8% -10.0% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 45.89M 44.84M 56.68M
Total Equity 37.49M 34.89M 41.83M
D/E Ratio 1.22 1.29 1.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,817,297 -1,433,447 -1,263,705 -1,141,891
Free Cash Flow -1,064,720 -1,173,966 -726,945